Patent · US Active

N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists

US9987274B2 · kind B2 · utility

3Cited by

6References

19Claims

0Family size

Assignee

Ogeda SA · BE

Inventors

Hamid R. Hoveyda · Brussels, BE
Guillaume Dutheuil · Vedrin, BE
Graeme L. Fraser · Bousval, BE

Key dates

Filing date	Dec 7, 2016
Grant date	Jun 5, 2018
Priority date	—
Expiry date	Dec 7, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for treating and/or preventing hot flashes, by administering, to a patient in need thereof, of a pharmaceutically effective amount of a compound of Formula I or a pharmaceutically acceptable solvate thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.